The stock's overall trend over the last six months has been negative, with a decline of 8.82% from the price of approximately $99.17 in early October 2025 to $90.42 as of March 31, 2026. The price action shows significant volatility, including a sharp drop in early November 2025, followed by a recovery attempt that has since faded. In the short term, the stock is down 8.15% over the past month, underperforming the broader market (SPY down 5.25%), but has managed a slight gain of 0.56% over the past three months, outperforming the SPY's 4.63% decline. The current price of $90.42 is positioned in the lower half of its 52-week range of $84.59 to $114.44, indicating it is closer to its yearly low than its high, reflecting ongoing bearish pressure.

Revenue for Q4 2025 was $2.24 billion, representing a year-over-year growth of 10.9% compared to the same quarter in 2024. However, profitability has been inconsistent; the net income margin for Q4 2025 was 6.2%, a significant drop from 11.8% in Q4 2024, and the quarterly net income of $139.5 million was well below the $239.5 million from the prior year. The company maintains a solid current ratio of 1.98, indicating good short-term liquidity, and a debt-to-equity ratio of 0.59 suggests a moderate and manageable level of leverage. Free cash flow for the trailing twelve months is a robust $1.85 billion, providing financial flexibility for operations, dividends, and potential share repurchases. Operational efficiency metrics show room for improvement, with a Return on Equity (ROE) of 5.55% and a Return on Assets (ROA) of 3.94%, both of which are relatively low, indicating suboptimal returns on shareholder and company assets.